SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Seattle Genetics (SGEN)
An SI Board Since November 2000
Posts SubjectMarks Bans
161 32 0
Emcee:  keokalani'nui Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
136SEATTLE--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN - News) today repnigel bates-12/7/2009
135Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb Diffuse Largkenhott-10/5/2009
134Seattle Genetics Introduces Novel Technology for Empowering Antibodies BOTHELL,nigel bates-9/22/2009
133An offering and a Deutsche Bank "Buy" rating finance.yahoo.comidos-8/13/2009
132Seattle Genetics - SGEN-NNM Buy - Price 9.35 on June 29 by Needham & Co. mopgcw-7/5/2009
131baker boys buy a bunch more..mopgcw-5/21/2009
130Message 25400473mopgcw-2/10/2009
129That's a good question and one I'd like answered myself. I assume itmcbio-2/5/2009
128Soooo, where do you suppose the share strength coming from? Inefficient market? Steve Lokness-2/5/2009
127SGEN has an $850 million dollar market cap with zero drugs in Phase III. Do youmcbio-2/5/2009
126SGEN in this market did a secondary! Not only did they manage to pull this off, Steve Lokness-2/5/2009
125Seattle Genetics Receives Orphan Drug Designations for SGN-35 in the United StatSteve Lokness-1/26/2009
124<b>Seattle Genetics, FDA agree on cancer study design</b> finance.yidos-1/21/2009
123Seattle Genetics Announces Initiation of SGN-40 Phase Ib Clinical Trial in Combimopgcw-6/2/2008
122April 21, 2008--Seattle Genetics (SGEN) announced in an 8-K that the company entjad-4/21/2008
121Seattle Genetics Announces Initiation of Phase Ib Clinical Trial of SGN-40 in Comopgcw-4/8/2008
120Seattle Genetics Initiates SGN-33 Clinical Trial in Combination with Revlimid(R)mopgcw-3/20/2008
119Hmmm, no thoughts on press release huh? From the release; <i>In FebruarSteve Lokness-12/8/2007
118Is this what has been moving the stock? biz.yahoo.com <i>Seattle GeneticSteve Lokness-12/7/2007
117Rather subdued response; biz.yahoo.com Seattle Genetics Reports Positive PhaseSteve Lokness-11/5/2007
116Seattle Genetics Reports Third Quarter 2007 Financial Results and Progress in Admopgcw-10/24/2007
115Seattle Genetics Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drmopgcw-10/24/2007
114Pre ASCO perhaps.idos-5/17/2007
113Hmmmm? Seems to be some buying by someone as it hits a new 52 week high again tSteve Lokness-5/17/2007
112No big news, the stock will probably slide down today simply because of the headidos-4/25/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News